1-20 of 126
Eric Deconinck
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS

Esteban Arrieta-Bolaños, Lars L. J. van der Burg, Tobias Gedde-Dahl, Marie Robin, Urpu Salmenniemi, Nicolaus Kröger, Ibrahim Yakoub-Agha, Anne Huynh, Charles Crawley, Eric Deconinck, Claude Eric Bulabois, Edouard Forcade, Eleni Tholouli, Joost G. K. van der Hem, Peter van Balen, Jorinde D. Hoogenboom, Liesbeth C. de Wreede, Florent Malard, Annalisa Ruggeri, Katharina Fleischhauer
Journal: Blood
Blood (2024) 144 (16): 1747–1751.
https://doi.org/10.1182/blood.2024024351
Published: 2024
Includes: Supplemental data
Journal Articles

Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma

Clinical Trials & Observations
Gilles Crochet, Gloria Iacoboni, Audrey Couturier, Emmanuel Bachy, Josu Iraola-Truchuelo, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Bastien Lesne, Mi Kwon, Romain Gounot, Nuria Martínez-Cibrian, Cristina Castilla-Llorente, Pau Abrisqueta, Manuel Guerreiro, Clémentine Sarkozy, Jose María Aspa-Cilleruelo, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Francesc Bosch, Pere Barba, Franck Morschhauser, Roch Houot
Journal: Blood
Blood (2024) 144 (3): 334–338.
https://doi.org/10.1182/blood.2024024526
Published: 2024
Includes: Supplemental data
Journal Articles

Analysis of Tagraxofusp Activity in AML-Pdc As a Single Agent and in Combination with BCL2 Inhibitors

Morgane Boichut, Margaux Poussard, Imane Belakri, Xavier Roussel, Sabeha Biichle, Maxime Fredon, Florian Renosi, Eric Deconinck, Christopher Brooks, Francine Garnache Ottou, Fanny Delettre
Journal: Blood
Blood (2023) 142 (Supplement 1): 2783.
https://doi.org/10.1182/blood-2023-186126
Published: 2023
Journal Articles

Durable Outcomes with Manageable Safety Leading to Prolonged Survival with Tagraxofusp for Treatment-Naive Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: Updated Results from a European Named Patient Program

Emanuele Angelucci, Eric Deconinck, David Manteigas, Michael Zuurman, Marco Herling
Journal: Blood
Blood (2023) 142 (Supplement 1): 547.
https://doi.org/10.1182/blood-2023-178734
Published: 2023
Journal Articles

Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)

Eric Deconinck, Berengere Gruson, Sabeha Biichle, Anne Roggy, Florian Renosi, Thomas Fournet, Maxime Desmarets, Gregory Tio, Tony Marchand, Mikael Roussel, Thibaut Leguay, Jean-Philippe Vial, Francoise Huguet, Francois Vergez, Emilie Chalayer, Khaoula Mahfoudi, Fressia Honeyman, Sebastien Maury, Nicolas Freynet, Caroline Bonmati, Veronique Latger-Cannard, Eve Gehlkopf, Caroline Bret, Damien Roos Weil, Magali Le Garff-Tavernier, Sophie Rigaudeau, Gandhi Laurent Damaj, Edouard Cornet, Remy Gressin, Marie-Christine Jacob, Delphine Martineau, Aguirre Mimoun, Alice Garnier, Marion Eveillard, Alban Villate, Emmanuelle Rault, Fanny Delettre, Francine Garnache Ottou
Journal: Blood
Blood (2023) 142 (Supplement 1): 1516.
https://doi.org/10.1182/blood-2023-173379
Published: 2023
Journal Articles

Outcome of Allogeneic Stem Cell Transplantation in FLT3-TKD-Mutated AML - a Study on Behalf of the Acute Leukemia Working Party of the EBMT

Thomas Heinicke, Myriam Labopin, Didier Blaise, Jaime Sanz, Ibrahim Yakoub-Agha, Thomas Cluzeau, Marco Ladetto, Jürgen Finke, Eric Deconinck, Jurjen Versluis, Urpu Salmenniemi, Andreas Neubauer, Eolia Brissot, Ali Bazarbachi, Arnon Nagler, Jordi Esteve, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 4976.
https://doi.org/10.1182/blood-2023-174233
Published: 2023
Journal Articles

Efficacy of Chimeric Antigen Receptor T-Cell Therapy Is Not Impaired By Previous Bispecific Antibody Treatment in Patients with Large B-Cell Lymphoma

Gloria Iacoboni, Gilles Crochet, Audrey Couturier, Emmanuel Bachy, Josu Iraola, Thomas Gastinne, Charles Herbaux, Tom Fradon, Mi Kwon, Romain Gounot, Nuria Martinez-Cibrian, Cristina Castilla-Llorente, Manuel Guerreiro, Clementine Sarkozy, Jose Aspa-Cilleruelo, Vincent Camus, Stephanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Pere Barba, Roch Houot, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 228.
https://doi.org/10.1182/blood-2023-185035
Published: 2023
Journal Articles

HLA Class I Mismatches Reduce Survival after HCT in the Ptcy Era: A Study By the EBMT Cellular Therapy and Immunobiology Working Party

Esteban Arrieta-Bolanos, Edouard F. Bonneville, Marie Robin, Tobias Gedde-Dahl, Urpu Salmenniemi, Nicolaus Kröger, Ibrahim Yakoub-Agha, Charles Crawley, Goda Choi, Annoek E. C. Broers, Edouard Forcade, Martin Carre, Xavier Poiré, Anne Huynh, Péter Reményi, Stig Lenhoff, Fabio Ciceri, Eleni Tholouli, Thomas Schröder, Eric Deconinck, Kristina Elisabet Carlson, Liesbeth C. de Wreede, Jorinde D. Hoogenboom, Florent Malard, Annalisa Ruggeri, Katharina Fleischhauer
Journal: Blood
Blood (2023) 142 (Supplement 1): 2178.
https://doi.org/10.1182/blood-2023-185945
Published: 2023
Journal Articles

Mixture Model to Predict the Cumulative Incidence of Relapses in Follicular Lymphoma : Need for Longer Follow-up or Alternative Outcomes

Stephanie Guidez, Sylvie Glaisner, Eric Van Den Neste, Emmanuel Gyan, Zora Marjanovic, Luc-Matthieu Fornecker, Eric Deconinck, Michel Fabbro, Veronique Dorvaux, Daniela Robu, Hisayuki Yokoyama, Nathalie A. Johnson, Matthew C. Cheung, Sylvia Snauwaert, María Casanova, Yasuhito Terui, Go Yamamoto, Yuvraj Choudhary, Joseph Ronald Mace, Donald P. Quick, Franck Morschhauser, Yohann Foucher
Journal: Blood
Blood (2023) 142 (Supplement 1): 7401.
https://doi.org/10.1182/blood-2023-189296
Published: 2023
Journal Articles

Conditioning Regimen Intensity and Donor Choice Do Not Impact Outcomes of Patients (pts) with Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in First Complete Remission (CR1): An EBMT Analysis

Razan Mohty, Myriam Labopin, Jean Henri Bouhris, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Anne Huynh, Eolia Brissot, Didier Blaise, Régis Peffault de Latour, Claude-Eric Bulabois, Eric Deconinck, Jakob Passweg, Edouard Forcade, Hélène Labussière-Wallet, Xavier Leleu, Anne-Lise Menard, Ali Bazarbachi, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 4876–4877.
https://doi.org/10.1182/blood-2022-165606
Published: 2022
Journal Articles

CAR T-Cell Therapy Remain Effective in Patients with Relapse/Refractory B-Cell Non-Hodgkin Lymphoma after Bispecific Antibodies Exposure: Results of a Lysa Study Based on the Descar-T Registry

Gilles Crochet, Couturier Audrey, Emmanuel Bachy, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Romain Gounot, Cristina Castilla-LLorente, Clementine Sarkozy, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Franck Morschhauser, Roch Houot
Journal: Blood
Blood (2022) 140 (Supplement 1): 4639–4641.
https://doi.org/10.1182/blood-2022-162594
Published: 2022
Journal Articles

Autologous Hematopoietic Cell Transplantation for T-Cell Prolymphocytic Leukemia - a Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Joanna Drozd-Sokolowska, Luuk Gras, Nienke Zinger, Jorge Sierra, Montserrat Rovira, Urpu Salmenniemi, Teresa Zudaire, Arancha Bermúdez, Goda Choi, Matthew P. Collin, Martin Kaufmann, Piotr Kozlowski, Xavier Poiré, Josep-Maria Ribera, Antonia Sampol, Keith Wilson, Michel A. Duchosal, Tobias Gedde-Dahl, Eric Deconinck, Milena Mirabile, Kavita Raj, Michel Van Gelder, Olivier Tournilhac, Donal P. McLornan, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2022) 140 (Supplement 1): 4848–4850.
https://doi.org/10.1182/blood-2022-166166
Published: 2022
Journal Articles

Preliminary Results from an Observational Multicenter Study of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm Treated with Tagraxofusp in the European Expanded Access Program

Eric Deconinck, Madhu Anant, David Manteigas, Carole Paley, Marcello Riggi, Marco Herling, Emanuele Angelucci
Journal: Blood
Blood (2022) 140 (Supplement 1): 8115–8116.
https://doi.org/10.1182/blood-2022-159942
Published: 2022
Journal Articles

Experience with IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Frontline Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju, Giovanni Martinelli, Elisabetta Todisco, Andrew A. Lane, Evelyn Acuña-Cruz, Eric Deconinck, Eunice S. Wang, Kendra Sweet, David A Rizzieri, Giovanni Marconi, Luca Mazzarella, Daniel J. DeAngelo, Pau Montesinos, Federica Gigli, Harry P. Erba, Marina Konopleva, Hagop Kantarjian, Roland B. Walter, Ahmed Aribi, Delphine Lebon, Moshe Y. Levy, Callum M Sloss, Kara E Malcolm, Patrick A Zweidler-McKay, Naval Daver
Journal: Blood
Blood (2021) 138 (Supplement 1): 1284.
https://doi.org/10.1182/blood-2021-146666
Published: 2021
Journal Articles

A Study of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, for Patients with Frontline and Relapsed/Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju, Giovanni Marconi, Elisabetta Todisco, Pau Montesinos, Andrew A. Lane, Kendra Sweet, Eunice S. Wang, Eric Deconinck, David A Rizzieri, Roland B. Walter, Ahmed Aribi, Delphine Lebon, Moshe Y. Levy, Luca Mazzarella, Giovanni Martinelli, Federica Gigli, Harry P. Erba, Evelyn Acuña-Cruz, Marina Konopleva, Hagop Kantarjian, Callum M Sloss, Jiuzhou Wang, Kara E Malcolm, Patrick A Zweidler-McKay, Daniel J. DeAngelo, Naval Daver
Journal: Blood
Blood (2021) 138 (Supplement 1): 4429.
https://doi.org/10.1182/blood-2021-146681
Published: 2021
Journal Articles

Treatment-Free Remissions in Newly Diagnosed CP CML Patients Treated with the Combination of Nilotinib + Pegylated Interferon Alpha 2a Versus Nilotinib Alone in the National Phase III Petals Trial

Franck E. Nicolini, Gabriel Etienne, Francoise Huguet, Agnès Guerci-Bresler, Aude Charbonnier, Martine Escoffre-Barbe, Viviane Dubruille, Hyacinthe Johnson-Ansah, Laurence Legros, Valerie Coiteux, Pascale Cony-Makhoul, Pascal Lenain, Lydia Roy, Philippe Rousselot, Denis Guyotat, Jean-Christophe Ianotto, Corentin Orvain, Eric Deconinck, Denis Caillot, Pascal Turlure, Stephane Courby, Philippe Quittet, Eric Hermet, Shanti Amé, Simona Lapusan, Stephane Morisset, Francois-Xavier Mahon, Delphine Rea, Stephanie Dulucq
Journal: Blood
Blood (2021) 138 (Supplement 1): 2553.
https://doi.org/10.1182/blood-2021-146412
Published: 2021
Journal Articles

Characteristics and Outcomes of Newly Diagnosed Multiple Myeloma Patients with and without Extramedullary Disease after Autologous Transplant and Maintenance Therapy: A Study from the Cmwp-EBMT

Nico Gagelmann, Dirk-Jan Eikema, Linda Koster, Tanja Netelenbos, Andrew McDonald, Anne-Marie Stoppa, Guido Kobbe, Achilles Anagnostopoulos, Gwendolyn Van Gorkom, Eric Deconinck, Claude-Eric Bulabois, Michel Delforge, Donald Bunjes, William Arcese, Péter Reményi, Maija Itälä-Remes, Lorenz Thurner, Zahit Bolaman, Yafour Nabil, Stephan Mielke, Hélène Labussière-Wallet, Patrick J Hayden, Meral Beksac, Stefan Schönland, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2021) 138 (Supplement 1): 485.
https://doi.org/10.1182/blood-2021-152391
Published: 2021
Journal Articles

Values of Hematopoietic Cell Transplantation-Specific Comorbidity Index, Comorbidity/Age Index and Augmented Comorbidity/Age Index in Recipients of Haploidentical Stem Cell Transplantation Using Ptcy As Gvhd Prophylaxis: A Retrospective Study of 223 Cases

Maxime Jullien, MD, Sylvie François, MD, Ana Berceanu, MD, Marie-Anne Couturier, MD, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Amandine Le Bourgeois, MD, Marion Klemencie, MD, Aline Schmidt, MDPhD, Mathilde Hunault, MDPhD, Etienne Daguindau, MD, Eric Deconinck, MDPhD, Gaelle Guillerm, MD, Aurelien Giltat, MD, Corentin Orvain, MD PhD, Sylvain Thepot, MD, Steven Le Gouill, MD PhD, Marie C Bene, PharmSci, PhD, Patrice Chevallier, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-138656
Published: 2020
Journal Articles

Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju, MD, Giovanni Martinelli, MD, Elisabetta Todisco, MDPhD, Andrew A Lane, MD PhD, Evelyn Acuña-Cruz, MD, Eric Deconinck, MDPhD, Eunice S. Wang, MD, Kendra L. Sweet, MD MS, David A Rizzieri, MD, Luca Mazzarella, MDPhD, Daniel J. DeAngelo, MD PhD, Pau Montesinos, MD PhD, Corrado Tarella, Harry P. Erba, MD PhD, Marina Konopleva, MD PhD, Hagop M. Kantarjian, MD, Callum M Sloss, PhD, Kara E Malcolm, RN, Patrick A Zweidler-McKay, MDPhD, Naval Daver, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–13.
https://doi.org/10.1182/blood-2020-139903
Published: 2020
Journal Articles

Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naval G. Daver, MD, Pau Montesinos, MD PhD, Daniel J. DeAngelo, MD, Eunice S. Wang, MD, Nikolaos Papadantonakis, MDPhDMSc, Eric Deconinck, MD PhD, Harry P. Erba, MD PhD, Naveen Pemmaraju, MD, Andrew A. Lane, MD PhD, David A. Rizzieri, MD, Kendra L. Sweet, MD, Giovanni Martinelli, Corrado Tarella, MD, Elisabetta Todisco, MD PhD, Marina Y Konopleva, MD PhD, Callum M. Sloss, PhD, Kerry Culm-Merdek, PhD, Patrick A. Zweidler-McKay, MD PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 734.
https://doi.org/10.1182/blood-2019-128648
Published: 2019